Annual SGA
$466.84 M
-$35.58 M-7.08%
December 31, 2023
Summary
- As of March 2, 2025, GDRX annual SGA is $466.84 million, with the most recent change of -$35.58 million (-7.08%) on December 31, 2023.
- During the last 3 years, GDRX annual SGA has fallen by -$249.74 million (-34.85%).
- GDRX annual SGA is now -34.85% below its all-time high of $716.59 million, reached on December 31, 2020.
Performance
GDRX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$115.49 M
-$5.56 M-4.59%
September 30, 2024
Summary
- As of March 2, 2025, GDRX quarterly SGA is $115.49 million, with the most recent change of -$5.56 million (-4.59%) on September 30, 2024.
- Over the past year, GDRX quarterly SGA has dropped by -$11.45 million (-9.02%).
- GDRX quarterly SGA is now -72.22% below its all-time high of $415.69 million, reached on December 31, 2020.
Performance
GDRX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$5.82 B
-$16.22 M-0.28%
September 30, 2024
Summary
- As of March 2, 2025, GDRX TTM SGA is -$5.82 billion, with the most recent change of -$16.22 million (-0.28%) on September 30, 2024.
- Over the past year, GDRX TTM SGA has dropped by -$6.27 billion (-1376.88%).
- GDRX TTM SGA is now -430.19% below its all-time high of -$1.10 billion.
Performance
GDRX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
GDRX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.1% | -9.0% | -1376.9% |
| 3 y3 years | -34.9% | -9.0% | -1376.9% |
| 5 y5 years | +314.8% | -9.0% | -1376.9% |
GDRX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -11.1% | at low | -18.6% | +7.3% | -5.0% | at low |
| 5 y | 5-year | -34.9% | +143.6% | -72.2% | +98.3% | -430.2% | at low |
| alltime | all time | -34.9% | +314.8% | -72.2% | +135.4% | -430.2% | at low |
GoodRx Holdings Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $115.49 M(-4.6%) | $491.72 M(-2.3%) |
| Jun 2024 | - | $121.04 M(-7.7%) | $503.17 M(+2.7%) |
| Mar 2024 | - | $131.07 M(+5.6%) | $489.77 M(+4.9%) |
| Dec 2023 | $466.84 M(-7.1%) | $124.12 M(-2.2%) | $466.84 M(+2.5%) |
| Sep 2023 | - | $126.93 M(+17.9%) | $455.43 M(-1.9%) |
| Jun 2023 | - | $107.65 M(-0.5%) | $464.26 M(-4.4%) |
| Mar 2023 | - | $108.14 M(-4.1%) | $485.69 M(-3.3%) |
| Dec 2022 | $502.42 M(-4.3%) | $112.71 M(-17.0%) | $502.42 M(-5.5%) |
| Sep 2022 | - | $135.76 M(+5.2%) | $531.58 M(+0.8%) |
| Jun 2022 | - | $129.08 M(+3.4%) | $527.41 M(+0.2%) |
| Mar 2022 | - | $124.87 M(-12.0%) | $526.30 M(+0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $524.90 M(-26.7%) | $141.87 M(+7.8%) | $524.90 M(-34.3%) |
| Sep 2021 | - | $131.60 M(+2.8%) | $798.73 M(-5.0%) |
| Jun 2021 | - | $127.96 M(+3.6%) | $840.73 M(+9.0%) |
| Mar 2021 | - | $123.48 M(-70.3%) | $771.02 M(+7.6%) |
| Dec 2020 | $716.59 M(+273.9%) | $415.69 M(+139.5%) | $716.59 M(+99.2%) |
| Sep 2020 | - | $173.59 M(+198.0%) | $359.75 M(+52.9%) |
| Jun 2020 | - | $58.25 M(-15.6%) | $235.21 M(+32.9%) |
| Mar 2020 | - | $69.05 M(+17.3%) | $176.96 M(+64.0%) |
| Dec 2019 | $191.66 M(+70.3%) | $58.85 M(+20.0%) | $107.91 M(+120.0%) |
| Sep 2019 | - | $49.05 M | $49.05 M |
| Dec 2018 | $112.54 M | - | - |
FAQ
- What is GoodRx Holdings annual SGA?
- What is the all time high annual SGA for GoodRx Holdings?
- What is GoodRx Holdings annual SGA year-on-year change?
- What is GoodRx Holdings quarterly SGA?
- What is the all time high quarterly SGA for GoodRx Holdings?
- What is GoodRx Holdings quarterly SGA year-on-year change?
- What is GoodRx Holdings TTM SGA?
- What is the all time high TTM SGA for GoodRx Holdings?
- What is GoodRx Holdings TTM SGA year-on-year change?
What is GoodRx Holdings annual SGA?
The current annual SGA of GDRX is $466.84 M
What is the all time high annual SGA for GoodRx Holdings?
GoodRx Holdings all-time high annual SGA is $716.59 M
What is GoodRx Holdings annual SGA year-on-year change?
Over the past year, GDRX annual SGA has changed by -$35.58 M (-7.08%)
What is GoodRx Holdings quarterly SGA?
The current quarterly SGA of GDRX is $115.49 M
What is the all time high quarterly SGA for GoodRx Holdings?
GoodRx Holdings all-time high quarterly SGA is $415.69 M
What is GoodRx Holdings quarterly SGA year-on-year change?
Over the past year, GDRX quarterly SGA has changed by -$11.45 M (-9.02%)
What is GoodRx Holdings TTM SGA?
The current TTM SGA of GDRX is -$5.82 B
What is the all time high TTM SGA for GoodRx Holdings?
GoodRx Holdings all-time high TTM SGA is -$1.10 B
What is GoodRx Holdings TTM SGA year-on-year change?
Over the past year, GDRX TTM SGA has changed by -$6.27 B (-1376.88%)